Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer.
Saved in:
| Title: | Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer. |
|---|---|
| Authors: | Titmarsh HF; The EPSRC and MRC Centre for Doctoral Training in Optical Medical Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom., von Kriegsheim A; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Wills JC; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., O'Connor RA; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom., Dhaliwal K; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom., Frame MC; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Pattle SB; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom., Dorward DA; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom., Byron A; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.; Division of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom., Akram AR; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Jun 16; Vol. 13, pp. 1194515. Date of Electronic Publication: 2023 Jun 16 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37397358 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Titmarsh+HF%22">Titmarsh HF</searchLink>; The EPSRC and MRC Centre for Doctoral Training in Optical Medical Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22von+Kriegsheim+A%22">von Kriegsheim A</searchLink>; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wills+JC%22">Wills JC</searchLink>; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22O'Connor+RA%22">O'Connor RA</searchLink>; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dhaliwal+K%22">Dhaliwal K</searchLink>; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Frame+MC%22">Frame MC</searchLink>; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pattle+SB%22">Pattle SB</searchLink>; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dorward+DA%22">Dorward DA</searchLink>; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Byron+A%22">Byron A</searchLink>; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.; Division of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Akram+AR%22">Akram AR</searchLink>; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh Bioquarter, Edinburgh, United Kingdom.; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2023 Jun 16; Vol. 13, pp. 1194515. <i>Date of Electronic Publication: </i>2023 Jun 16 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37397358 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2023.1194515 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1194515 Titles: – TitleFull: Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Titmarsh HF – PersonEntity: Name: NameFull: von Kriegsheim A – PersonEntity: Name: NameFull: Wills JC – PersonEntity: Name: NameFull: O'Connor RA – PersonEntity: Name: NameFull: Dhaliwal K – PersonEntity: Name: NameFull: Frame MC – PersonEntity: Name: NameFull: Pattle SB – PersonEntity: Name: NameFull: Dorward DA – PersonEntity: Name: NameFull: Byron A – PersonEntity: Name: NameFull: Akram AR IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 06 Text: 2023 Jun 16 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
